Immunology
Discovered a new mechanism against Epstein-Barr virus infection
Antibodies against SARS-CoV-2 remain stable seven months after the infection
Immunity anniversary: antibodies against SARS-CoV-2 remain one year after infection
Launched a clinical trial to prevent the side effects of COVID-19
SARS-Cov-2 antibodies detected three months after the infection
Drugs and antibodies: the strategies of two IMIM groups to block SARS-CoV-2
The antiviral drug remdesivir reduces the time to recovery in COVID-19 patients
New protection biomarker against cytomegalovirus in kidney transplant patients
New key element to control interferons during the immune response
“Being able to see the sea everyday from work is wonderful”
